View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Lupus News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 18, 2022
2 min read
Save

Genetics vs. environment: Experts still unraveling links in lupus pathogenesis

Genetics vs. environment: Experts still unraveling links in lupus pathogenesis

Experts are still trying to understand the interplay between genetic and environmental factors in lupus disease pathogenesis, according to a presenter at the 2022 Association of Women in Rheumatology Annual Conference.

SPONSORED CONTENT
August 16, 2022
2 min read
Save

No adverse childhood outcomes through 17 years after prenatal hydroxychloroquine exposure

No adverse childhood outcomes through 17 years after prenatal hydroxychloroquine exposure

Prenatal exposure to hydroxychloroquine in birthing parents with systemic lupus erythematosus results in no significant adverse outcomes in children from breast feeding through 17 years, according to data published in Rheumatology.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
August 11, 2022
1 min read
Save

Professor honored for endogenous retrovirus expression research in patients with lupus

Professor honored for endogenous retrovirus expression research in patients with lupus

The Lupus Research Alliance has awarded the 2022 Lupus Insight Prize to Akiko Iwasaki, PhD, for her work connecting endogenous retroviruses and systemic lupus erythematosus.

SPONSORED CONTENT
August 11, 2022
2 min read
Save

Systemic inflammation in psoriasis accelerates CVD risk

Systemic inflammation in psoriasis accelerates CVD risk

LOUISVILLE, Ky. — Persistent, chronic inflammation seen in moderate to severe psoriasis is associated with plaque destabilization and rupture that drives MI, and biologic treatment can reduce CV risk, according to a speaker.

SPONSORED CONTENT
August 05, 2022
2 min read
Save

Different types of arthritis ‘present very differently’ in synovium, synovial fluid

Different types of arthritis ‘present very differently’ in synovium, synovial fluid

ORLANDO — Understanding the nature and role of the synovium and synovial fluid is critical to managing various types of arthritis, according to a presenter at the 2022 Rheumatology Nurses Society Annual Conference.

SPONSORED CONTENT
July 29, 2022
8 min read
Save

Denial of methotrexate prescriptions post-Roe yields ‘condemnation’

Denial of methotrexate prescriptions post-<i>Roe</i> yields &lsquo;condemnation&rsquo;

The June 24 Supreme Court decision to overturn Roe vs. Wade continues to reverberate across all of health care, including rheumatology, dermatology and cancer treatment — and in this instance all three at once.

SPONSORED CONTENT
July 27, 2022
1 min read
Save

Belimumab becomes first FDA-approved drug for pediatric lupus nephritis

Belimumab becomes first FDA-approved drug for pediatric lupus nephritis

The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.

SPONSORED CONTENT
July 14, 2022
1 min read
Save

HHS: Pharmacies cannot deny prescriptions to patients over abortion concerns

HHS: Pharmacies cannot deny prescriptions to patients over abortion concerns

Federal law prohibits pharmacies from refusing to fill prescriptions that may end a pregnancy to patients who are able to become pregnant, according to a newly released HHS guidance.

SPONSORED CONTENT
July 12, 2022
2 min read
Save

Vitamin D, fish oil ‘unlikely’ to impact RMD progression

Vitamin D, fish oil &lsquo;unlikely&rsquo; to impact RMD progression

Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.

SPONSORED CONTENT
July 06, 2022
3 min read
Save

Trio of anifrolumab lupus trials show concordant BICLA, SRI(4) responses in most patients

Trio of anifrolumab lupus trials show concordant BICLA, SRI(4) responses in most patients

Most patients with systemic lupus erythematosus across a trio of anifrolumab trials demonstrated concordant outcomes on BILAG-based Composite Lupus Assessment and SLE Responder Index responses, according to data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails